Sam Eiber

Stock Analyst at BTIG

(0.24)

# 4,356

Out of 5,043 analysts

6

Total ratings

25%

Success rate

-13.98%

Average return

Main Sectors:

Top Industries:

Medical Devices Drug Manufacturers - Specialty & Generic

Stocks Rated by Sam Eiber

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	EOLS Evolus	Reiterates: Buy	$18	$7.24	+148.62%	3	Sep 8, 2025
	INMD InMode	Downgrades: Neutral	n/a	$15.65	-	2	Apr 29, 2025
	APYX Apyx Medical	Initiates: Neutral	n/a	$3.13	-	1	Oct 17, 2024

Evolus

Sep 8, 2025

Reiterates: Buy

Price Target: $18

Current: $7.24

Upside: +148.62%

InMode

Apr 29, 2025

Downgrades: Neutral

Price Target: n/a

Current: $15.65

Upside: -

Apyx Medical

Oct 17, 2024

Initiates: Neutral

Price Target: n/a

Current: $3.13

Upside: -